Visco G, Giannuzzi R, Paglia M G, Visco Comandini U
L. Spallanzani Hospital for Infectious Diseases, Rome, Italy.
Biomater Artif Cells Immobilization Biotechnol. 1993;21(2):265-81. doi: 10.3109/10731199309117363.
After first adventurous attempts to apply perfusion techniques to the treatment of liver diseases, more extensive experiences have been acquired in the last twenty years, not only in acute hepatic failure but also in some chronic liver diseases (mainly in CAH:chronic active hepatitis, and in primary biliary cirrhosis) and in a severe complication of them, that is cryoglobulinemia. Some experiences on this field that are found in literature, using both plasma exchange and hemoperfusion, are reviewed and some personal data are reported: 15 patients with acute viral liver failure (survival rate: 33%) and 5 patients with a CAH-linked (3 viral and 2 autoimmune) cryoglobulinemia, in whom a good control of the disease parameters was obtained.
在首次尝试将灌注技术大胆应用于肝脏疾病治疗之后,过去二十年间积累了更为广泛的经验,不仅在急性肝衰竭方面,而且在一些慢性肝病(主要是慢性活动性肝炎和原发性胆汁性肝硬化)及其一种严重并发症即冷球蛋白血症方面。本文回顾了文献中在该领域使用血浆置换和血液灌注的一些经验,并报告了一些个人数据:15例急性病毒性肝衰竭患者(生存率:33%)和5例与慢性活动性肝炎相关的(3例病毒性和2例自身免疫性)冷球蛋白血症患者,这些患者的疾病参数得到了良好控制。